losartan has been researched along with Lead Poisoning in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Lead Poisoning: Poisoning that results from chronic or acute ingestion, injection, inhalation, or skin absorption of LEAD or lead compounds.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan treatment also decreased ANG II and TGF-β." | 1.39 | Renin angiotensin system blockade ameliorates lead nephropathy. ( Chiou, TT; Hsu, CY; Huang, PC; Lee, CT; Lee, YT; Ng, HY; Tain, YL, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, HY | 1 |
| Tain, YL | 1 |
| Lee, YT | 1 |
| Hsu, CY | 1 |
| Chiou, TT | 1 |
| Huang, PC | 1 |
| Lee, CT | 1 |
| Silveira, EA | 1 |
| Siman, FD | 1 |
| de Oliveira Faria, T | 1 |
| Vescovi, MV | 1 |
| Furieri, LB | 1 |
| Lizardo, JH | 1 |
| Stefanon, I | 1 |
| Padilha, AS | 1 |
| Vassallo, DV | 1 |
2 other studies available for losartan and Lead Poisoning
| Article | Year |
|---|---|
Renin angiotensin system blockade ameliorates lead nephropathy.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; A | 2013 |
Low-dose chronic lead exposure increases systolic arterial pressure and vascular reactivity of rat aortas.
Topics: Acetophenones; Animals; Antioxidants; Aorta; Blood Pressure; Chronic Disease; Cyclooxygenase 2 Inhib | 2014 |